Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

ClinicalTrials.gov ID: NCT00314652

Public ClinicalTrials.gov record NCT00314652. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind Placebo-Controlled Study of Buprenorphine Transdermal System (BTDS) in Patients With Osteoarthritis of the Hip or Knee

Study identification

NCT ID
NCT00314652
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Purdue Pharma LP
Industry
Enrollment
260 participants

Conditions and interventions

Conditions

Interventions

  • Buprenorphine transdermal delivery system Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 1999
Primary completion
Not listed
Completion
Sep 30, 1999
Last update posted
May 2, 2006

1999

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
19
Facility City State ZIP Site status
Hawthorne & York, International, Ltd. Phoenix Arizona 85008
Arizona Research Center, LLC Phoenix Arizona 85023
ACRC/Arizona Clinical Research Tucson Arizona 85712
Advanced Clinical Therapeutics Tucson Arizona 85712
San Diego Arthritis and Osteoporosis Research San Diego California 92120
Scripps Clinic Rancho Bernardo San Diego California 92128
Clinical Research Consultants, Inc. Trumbull Connecticut 06611
Tampa Bay Medical Research, Inc. Clearwater Florida 33761
University Clinical Research DeLand Florida 32720
Gainesville Clinical Research Center Gainesville Florida 32605
Physicians Research Associates Jacksonville Jacksonville Florida 32216
University Clinical Research, Inc. Pembroke Pines Florida 33024
Gold Coast Research, Inc. Weston Florida 33331
MediSphere Medical Research Center, LLC Evansville Indiana 47714
Westside Family Medical Center Kalamazoo Michigan 49009
Center for Pharmaceutical Research Kansas City Missouri 64114
NJP Clinical Research Passaic New Jersey 07055
PW Clinical Research, LLC Winston-Salem North Carolina 27103
New Century Research Center, Ltd. Beaverbrook Ohio 45431
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Mid-South Clinical Research Institute Memphis Tennessee 38120
Advanced Clinical Research Salt Lake City Utah 84102

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00314652, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 2, 2006 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00314652 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →